|
US5602116A
(en)
|
1988-08-02 |
1997-02-11 |
Bone Care International, Inc. |
Method for treating and preventing secondary hyperparathyroidism
|
|
US5869473A
(en)
|
1988-08-02 |
1999-02-09 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
CA1333616C
(en)
|
1989-03-09 |
1994-12-20 |
Hector F. Deluca |
19-nor-vitamin d compounds
|
|
US5246925A
(en)
|
1989-03-09 |
1993-09-21 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D compounds for use in treating hyperparathyroidism
|
|
AU9131091A
(en)
|
1990-11-07 |
1992-06-11 |
Scripps Research Institute, The |
Peptides that inhibit platelet binding of adhesion molecules
|
|
US6011068A
(en)
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US6031003A
(en)
|
1991-08-23 |
2000-02-29 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
WO1995006056A1
(en)
|
1993-08-20 |
1995-03-02 |
University Of Medicine & Dentistry Of New Jersey |
Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same
|
|
CA2145214A1
(en)
|
1995-02-28 |
1996-08-29 |
Rick E. Preddie |
Agents for pre-symptomatic diagnosis, prevention and cure huntington's disease (hd) in humans
|
|
US5688489A
(en)
|
1995-09-15 |
1997-11-18 |
Resolution Pharmaceuticals, Inc. |
Non-receptor mediated imaging agents
|
|
US5895368A
(en)
*
|
1996-09-23 |
1999-04-20 |
Medisystems Technology Corporation |
Blood set priming method and apparatus
|
|
US6165977A
(en)
|
1996-10-18 |
2000-12-26 |
Board Of Trustees Of The Leland Stanford Junior University |
Isozyme-specific activators of protein kinase C methods and compositions
|
|
US6258774B1
(en)
|
1998-03-19 |
2001-07-10 |
University Of Medicine And Dentistry Of New Jersey |
Carrier for in vivo delivery of a therapeutic agent
|
|
JP2000336099A
(ja)
|
1999-05-27 |
2000-12-05 |
Sekisui Chem Co Ltd |
ペプチド及びｃ型肝炎抗体検出用試薬
|
|
US6274169B1
(en)
|
1999-08-02 |
2001-08-14 |
Abbott Laboratories |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
|
|
US6051567A
(en)
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
|
JP2004504295A
(ja)
|
2000-07-18 |
2004-02-12 |
ボーン ケア インターナショナル インコーポレイテッド |
安定化１α−ヒドロキシビタミンＤ
|
|
US20080249016A1
(en)
|
2000-09-18 |
2008-10-09 |
Sanos Bioscience A/S |
Use of GLP-2 in a combination treatment for bone-related disorders
|
|
US20020168354A1
(en)
|
2000-11-10 |
2002-11-14 |
Daria Mochly-Rosen |
psiepsilonRack peptide composition and method for protection against tissue damage due to ischemia
|
|
CA2434643C
(en)
|
2001-01-18 |
2013-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptides for activation and inhibition of.delta.pkc
|
|
AU2002240312A1
(en)
|
2001-02-08 |
2002-08-19 |
Pankaj Paranjp |
Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents using polymer conjugates
|
|
US20030036627A1
(en)
|
2001-02-16 |
2003-02-20 |
Montelaro Ronald C. |
Virus derived antimicrobial peptides
|
|
US7253146B2
(en)
|
2001-02-23 |
2007-08-07 |
Polyphor Ltd |
Template-fixed peptidomimetics with antimicrobial activity
|
|
JP2005287302A
(ja)
|
2002-04-03 |
2005-10-20 |
Haruhiko Fujiwara |
ポリペプチドの架橋方法
|
|
AU2003299496A1
(en)
|
2002-05-14 |
2004-05-25 |
Bristol-Myers Squibb Company |
Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof
|
|
WO2004093821A2
(en)
|
2003-04-22 |
2004-11-04 |
Hawaii Biotech, Inc. |
Treatment of anthrax infection using inhibitors of lethal factor protease activity
|
|
CA2543072A1
(en)
|
2003-11-05 |
2005-06-02 |
Pevion Biotech Ltd. |
Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens
|
|
US20050187156A1
(en)
|
2003-12-11 |
2005-08-25 |
Daria Mochly-Rosen |
Isozyme-specific antagonists of protein kinase C
|
|
US7939634B2
(en)
|
2004-01-27 |
2011-05-10 |
Compugen Ltd. |
Polynucleotides encoding polypeptides and methods using same
|
|
US7265092B2
(en)
|
2004-09-30 |
2007-09-04 |
Kai Pharmaceuticals, Inc. |
Pharmaceutical formulation
|
|
ITME20040015A1
(it)
*
|
2004-12-07 |
2005-03-07 |
Vincenzo Savica |
Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
|
|
US20070066514A1
(en)
|
2005-08-30 |
2007-03-22 |
Acologix, Inc. |
Regulation of mineral and skeletal metabolism
|
|
WO2007038172A2
(en)
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Guanidinium carriers
|
|
JP5645408B2
(ja)
*
|
2006-11-16 |
2014-12-24 |
カイ ファーマシューティカルズ インコーポレーティッド |
副甲状腺機能亢進症および高カルシウム血症性障害の治療のためのポリカチオン性カルシウムモジュレーターペプチド
|
|
US8067532B2
(en)
|
2007-01-19 |
2011-11-29 |
Kai Pharmaceuticals, Inc. |
Modifications of peptide compositions to increase stability and delivery efficiency
|
|
AU2008308679B2
(en)
|
2007-10-02 |
2015-01-29 |
Marina Biotech, Inc. |
Lipopeptides for delivery of nucleic acids
|
|
EP2229473A4
(en)
|
2007-12-07 |
2011-02-02 |
Steven A Goldstein |
IDENTIFICATION OF TOXIN LIGANDS
|
|
EP2459208B1
(en)
|
2009-07-29 |
2016-09-28 |
Kai Pharmaceuticals, Inc. |
Therapeutic agents for reducing parathyroid hormone levels
|